Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A human autoantibody to peroxisomes.

R Holm, P I Gaarder, L Helgeland

    Clinical and Experimental Immunology
    |August 1, 1985
    PubMed
    Summary

    Researchers identified a novel IgG autoantibody in 29 patients that targets a peroxisomal antigen. This autoantibody causes characteristic granular staining in liver, kidney, and stomach tissues, but lacks clear clinical correlations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Corrigendum to 'Is Oral Absorption of Vigabatrin Carrier-mediated?' [European Journal of Pharmaceutical Sciences 69 (2015) 10-18].

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2021
    Same author

    Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2021
    Same author

    Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2020
    Same author

    Solution or suspension - Does it matter for lipid based systems? In vivo studies of chase dosing lipid vehicles with aqueous suspensions of a poorly soluble drug.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2017
    Same author

    A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives.

    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2017
    Same author

    Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.

    Scandinavian journal of immunology·2015

    Area of Science:

    • Immunology
    • Autoimmunity
    • Cell Biology

    Background:

    • Autoantibodies play a crucial role in autoimmune diseases.
    • Non-organ specific autoantibodies can target various cellular components.
    • Understanding autoantibody targets is key to diagnosing and managing autoimmune conditions.

    Purpose of the Study:

    • To characterize a novel complement-fixing IgG autoantibody found in a cohort of patients.
    • To identify the specific antigen targeted by this autoantibody.
    • To investigate potential clinical correlations associated with the autoantibody.

    Main Methods:

    • Patient cohort recruitment (n=29).
    • Immunofluorescence and complement fixation assays using rat liver subcellular fractions.
    • Quantitative complement fixation and absorption studies.
    • Indirect immunofluorescence for antigen localization.

    Main Results:

    • A complement-fixing, non-organ specific IgG autoantibody was identified in 29 patients.
    • The autoantibody exhibited characteristic granular staining of liver cells, proximal kidney tubules, and stomach surface epithelium.
    • Studies confirmed the autoantibody reacts with a peroxisomal antigen in rat liver.
    • No significant clinical correlations were found with the presence of this autoantibody.

    Conclusions:

    • A novel autoantibody targeting a peroxisomal antigen has been characterized.
    • This autoantibody displays a distinct tissue staining pattern.
    • Further research is needed to elucidate the clinical significance, if any, of this peroxisomal autoantibody.

    Related Experiment Videos